Expression pattern of apurinic/apyrimidinic endonuclease in sinonasal squamous cell carcinoma

Otolaryngology - Head and Neck Surgery (United States)

Volumn 147, Issue 4, 2012, Pages 788-795

  Lee, Jin Woo ^a   Jin, Jun ^a   Rha, Ki Sang ^a   Kim, Yong Min ^a  

^a Chungnam National University   (South Korea)

Author keywords

APE 1; inverted papilloma; metastasis; squamous cell carcinoma; tumor invasion

Indexed keywords

APURINIC APYRIMIDINIC ENDONUCLEASE 1; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CASE CONTROL STUDY; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISTANT METASTASIS; ENDOSCOPIC SINUS SURGERY; FEMALE; GROUPS BY AGE AND SEX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVERTED PAPILLOMA; MALE; NOSE POLYP; PARANASAL SINUS CARCINOMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NOSE NEOPLASMS; PAPILLOMA, INVERTED; PARANASAL SINUS NEOPLASMS; RETROSPECTIVE STUDIES; STAINING AND LABELING;

EID: 84870475186     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812449987     Document Type: Article

References (23)

1. Batsakis JG, Rice DH, Solomon AR. The pathology of head and neck tumors: squamous and mucous-gland carcinomas of nasal cavity, paranasal sinuses, and larynx, part 6. Head Neck Surg. 1980 ; 2: 497-508 (Pubitemid 10085035)
2. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress?. Cancer. 2001 ; 92: 3012-3029
3. Demple B, Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem. 1994 ; 63: 915-948 (Pubitemid 24218652)
4. Kishor KB, Anil KM, Sankar M. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal. 2009 ; 11: 621-638
5. Al A, Gossage L, Fareed KR, et al. Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. Cancer Res. 2010 ; 102: 704-709
6. Grigory LD. Base excision repair targets for cancer therapy. Cancer Res. 2011 ; 1: 845-851
7. Carlos BS, Iwakuma T, Izumi T. Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway. Oncogene. 2009 ; 23: 1616-1625
8. Melissa LF, Yanlin J, Rajeshkumar NV, et al. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth. Mol Cancer Ther. 2011 ; 10: 1698-1708
9. Lavertu P, Roberts JK, Kraus DH, et al. Squamous cell carcinoma of the paranasal sinuses: the Cleveland clinic experience 1977-1986. Laryngocsope. 1989 ; 99: 1130-1136 (Pubitemid 19274804)
10. Tanvetyanon T, Qin D, Padhya T, Kapoor R, McCaffrey J, Trotti A. Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: reported 6 cases with systemic review and analysis. Am J Otolaryngol. 2009 ; 30: 38-43
11. Lesperance MM, Esclamado RM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope. 1995 ; 105: 178-183
12. Vrabec DP. The inverted Schneiderian papilloma: a 25-year study. Laryngoscope. 1994 ; 104: 582-605 (Pubitemid 24145433)
13. Mendenhall WM, Hinerman RW, Malyapa RS, et al. Inverted papilloma of the nasal cavity and paranasal sinuses. Am J Clin Oncol. 2007 ; 30: 560-563 (Pubitemid 47537960)
14. Mannetje A, Kogevinas M, Luce D, et al. Sinonasal cancer, occupation, and tobacco smoking in European women and men. Am J Ind Med. 1999 ; 36: 101-107 (Pubitemid 29283632)
15. Khademi B, Moradi A, Hoseini S, Mohammadianpanah M. Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg. 2009 ; 13: 191-199
16. Meira LB, Cheo DL, Hammer RE, Burns DK, Reis A, Friedberq EC. Genetic interaction between HAP1/REF-1 and p53. Nat Genet. 1997 ; 17: 145
17. Zaky A, Busso C, Izumi T, et al. Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res. 2008 ; 36: 1555-1566 (Pubitemid 351426108)
18. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006 ; 444: 756-760 (Pubitemid 44949604)
19. Robertson KA, Bullock HA, Xu Y, et al. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. ; 2001 ; 2001. 2220.
20. Yang S, Irani K, Heffron SE, Jurnak F, Meyskens FL. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther. 2005 ; 4: 1923-1935 (Pubitemid 43056975)
21. Wang D, Xiang DB, Yang XQ, et al. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells. Lung Cancer. 2009 ; 66: 298-304
22. Koukourakis MI, Giatromanolaki A, Kakolyris S, et al. Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. Int J Radiat Oncol Biol Phys. 2001 ; 50: 27-36
23. Kakolyris S, Kaklamanis L, Engels K, et al. Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence. Cancer Res. 1997 ; 57: 1794-1797 (Pubitemid 27199675)